Journal of Turkish Clinical Biochemistry

The official publication of Turkish Society of Clinical Biochemistry

Diamond OA
No APCs
First Decision
30 Days
Indexed In
TR Dizin
Original Research
April 01, 2013
JTCB. 2013 Apr 1; 11 (1) : 007-014

Comparison of Patient Samples Between Coagulation Analyzers

1 Gazi Üniversitesi Tıp Fakültesi, Tıbbi Biyokimya Anabilim Dalı, Ankara

Abstract

Objective: If a new analyzer in the laboratories is considered to be used, method comparison should be done. Two analyzers should be compared in order to evaluate accuracy of the new analyzer. In our study, we aimed to compare the performance of new coagulation analyzer with the one in our laboratory.

Materials and Methods: For method comparison; samples from 78 subjects admitted to our emergency laboratory, were collected and prothrombin time (PT), international normalised ratio (INR), partial thromboplastin time (PTT) tests were analyzed in Sysmex CA-500 and MTX II Coag-A-Mate analyzers. We used MedCalc and Excel programs to evaluate the results by the way of regression analysis and Bland-Altman graphics.

Results: As a result of linear regression analysis we obtained PT r=0.961, INR r=0.965 and APTT r=0.854. r values were smaller than 0.975, so we applied Passing-Bablok regression analysis and found systematic and random errors between analyzers. We observed systematic errors in Bland- Altman graphics for three of the tests. In our study MTX II Coag-A-Mate analyzer gave higher PTZ and APTT results; lower INR results than Sysmex CA-500.

Conclusion: Although there were systematic and random errors between results, the new analyzer was acceptable because bias was smaller than CLIA total allowable error.

Citation

Eren, Sevim Eşmedere, Banu Çaycı, Gökçe Atikeler, Özlem Gülbahar, and Hatice Paşaoğlu. 2013. “Comparison of Patient Samples Between Coagulation Analyzers”. Journal of Turkish Clinical Biochemistry 11 (1):007-014. https://turkclinbiochem.org/index.php/pub/article/view/177.

Publish with JTCB

Diamond Open Access

Fully Diamond OA with no APCs and no submission fees. Your research is freely available to readers worldwide from the day it publishes.

30-Day First Decision

Double-blind peer review from an active editorial team returns a first decision in about 30 days, keeping your manuscript moving.

Global Platform

Backed by the Turkish Society of Clinical Biochemistry, JTCB welcomes submissions from researchers worldwide and reaches an international laboratory audience.

Focused Laboratory Scope

Method validation, analyzer comparisons, reference intervals, quality indicators, preanalytical studies, and instructive clinical case reports.

Credible and Discoverable

All manuscripts publish in English and follow ICMJE and COPE guidelines, with Crossref DOIs and TR Dizin indexing ensuring global discoverability.